The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index; 3 of the 8 sources its claims cite were checked for support.
Outcomes of implementation of the FilmArray meningoencephalitis panel in a tertiary hospital between 2017 and 2020.
Open accessAbstract
BACKGROUND: Acute meningoencephalitis is encountered commonly in the acute hospital setting and is associated with significant morbidity and mortality, in addition to significant healthcare costs. Multiplex PCR panels now allow syndromic testing for central nervous system infection. The BioFire® FilmArray® Meningoencephalitis (ME) allows testing of 14 target pathogens using only 0.2mls of cerebrospinal fluid (CSF). We conducted a retrospective observational study to assess the performance of the assay and secondarily to observe the clinical utility of negative results by comparing clinical outcomes of aseptic meningitis to bacterial and viral meningoencephalitis. METHODS: Data for CSF samples tested using the FilmArray ME panel from October 2017 to October 2020 were analysed. Detection of bacterial and viral targets was analysed. Admission to critical care area, 90-day readmission rates, average length of stay and 30-day and 90-day mortality were analysed for three groups with following diagnoses: bacterial meningitis, viral meningoencephalitis, or aseptic meningitis. RESULTS: From October 2017 to October 2020, 1926 CSF samples were received in the Clinical Microbiology laboratory. Of those, 543 CSF samples from 512 individual patients were tested using the FilmArray ME panel. Twenty-one bacterial targets and 56 viral targets were detected during the study period. For viral targets, the cumulative specificity was 98.9% (95% confidence interval: 93.1-99.9) when compared to the reference laboratory methods. The outcomes for 30- and 90-day mortality of the aseptic meningitis group were non-inferior relative to the viral meningoencephalitis and bacterial meningitis group. Patients with bacterial meningitis had a longer average length of stay. Aseptic meningitis was associated with a higher 90-day readmission rate than the other 2 groups, but without statistical significance. CONCLUSION: In our hands, implementation of the FilmArray ME panel was relatively straightforward. We experienced a transition in our workflow processes that enabled streamlining of CSF diagnostics and the safe removal of Gram staining in those samples being tested by this molecular assay. Coupled to this improvement, there was a positive clinical impact on patient care due to rapid turnaround time to results.
Overview
CoChat Summary
## TL;DR
This retrospective single-center study evaluated 543 CSF samples from 512 patients tested with the FilmArray ME panel over 3 years and found the assay was straightforward to implement and clinically useful, especially for rapid management of suspected CNS infection. The panel had high viral specificity (98.9%) but lower viral sensitivity (53.8%) versus reference methods, and negative results in the aseptic meningitis group were associated with non-inferior mortality outcomes.
## Key findings
- From October 2017 to October 2020, 543 CSF samples from 512 patients were tested; 78/543 (14.4%) were positive overall, including 22 bacterial and 56 viral detections.
- For viral targets, cumulative specificity was 98.9% (95% CI 93.1–99.9) and sensitivity was 53.8% (26.1–79.6) versus reference laboratory methods; the authors note this sensitivity should be interpreted with caution because only 13 positive viral samples underwent duplicate testing.
- Compared with viral or aseptic meningitis, bacterial meningitis was associated with higher critical care admission (66.7% vs 3.6% vs 7.6%, p < 0.001) and longer average length of stay (20.5 vs 11.3 vs 12.9 days, p = 0.009).
- No statistically significant differences were seen in 30-day or 90-day all-cause mortality across bacterial, viral, and aseptic meningitis groups; 90-day readmission was higher in aseptic meningitis (15.1% vs 9.5% and 11.1%) but not significant (p = 0.722).
## Methods
- Retrospective observational study at University Hospital Limerick, a 455-bed tertiary referral centre in Ireland, including all patients who had CSF obtained by lumbar puncture and tested with the FilmArray ME panel from October 2017 to October 2020.
- Outcome comparison across three diagnostic groups: bacterial meningitis, viral meningoencephalitis, and aseptic meningitis; outcomes included critical care admission, 30- and 90-day mortality, 90-day readmission, and average length of stay.
- Statistical analysis used SPSS v26.0; Kruskal-Wallis tests were used for categorical data and one-way ANOVA for continuous data, with p ≤ 0.05 considered significant.
## Limitations
- The authors state the study’s main limitations were its retrospective design and inability to confirm a causal relationship between FilmArray results and individual patient outcomes.
- They also state they had no confirmed Cryptococcus neoformans cases, limiting assessment of panel performance for that target; findings may not generalize to settings with higher HIV prevalence or where pathogens such as West Nile virus or Japanese encephalitis virus are endemic.
- The paper says it was not designed to define morbidity differences between groups and may have missed differences; it also could not confirm the impact on antimicrobial/antiviral prescribing because electronic patient or prescribing records were unavailable.
- Evident from the text: bacterial performance characteristics could not be fully assessed because there was no gold-standard comparator and too few samples were referred for molecular confirmation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
2 Valid · 1 Not valid · 5 Not checked · 47 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Ten out of twelve positive results for HHV-6, of which 5 were confirmed by testing in the NVRL, were deemed not clinically significant based on clinical criteria and likely reflect chromosomal integration of the virus without evidence of meningoencephalitis [27].”
§ Outcomes of implementation of the FilmArray meningoencephalitis panel in a tertiary hospital between 2017 and 2020 > Discussion
What the sources say
- Supportedcites [27] PE Pellett, 2012, Chromosomally integrated human herpesvirus 6: questions and answers., Rev Med Virol. source
In “Will cerebrospinal fluid from individuals with chromosomally integrated human herpesvirus 6 contain human herpesvirus 6 DNA?” (p. 150), the review explains that chromosomal integration can produce a positive CSF HHV-6 PCR result. Its section on active infection says physicians must use clinical judgment because PCR alone cannot establish active disease. The ten results and their clinical assessment are the citing study’s own findings; the review supports the proposed interpretation, not a diagnosis of those individuals. (LLM, conf=0.86)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The FilmArray ME panel detects E. coli strains with K1 capsular polysaccharide only.”
§ Outcomes of implementation of the FilmArray meningoencephalitis panel in a tertiary hospital between 2017 and 2020 > Discussion
What the sources say
- Could not verifycites [25] Y Yao, 2006, Genomic comparison of Escherichia coli K1 strains isolated from the cerebrospinal fluid of patients with meningitis, Infect Immun sourceExperimental — accuracy not yet measured
The Results describe genomic analysis of 11 E. coli K1 strains and list the K1 capsule among their virulence factors; they do not evaluate the FilmArray ME panel. Searches for FilmArray and diagnostic detection found no passage establishing which strains that panel detects. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Although E. coli isolates possessing the K1 capsular polysaccharide are dominant, an estimated 20% do not carry the specific target for the FilmArray ME panel [25].”
§ Outcomes of implementation of the FilmArray meningoencephalitis panel in a tertiary hospital between 2017 and 2020 > Discussion
What the sources say
- Partly supportedcites [25] Y Yao, 2006, Genomic comparison of Escherichia coli K1 strains isolated from the cerebrospinal fluid of patients with meningitis, Infect Immun sourceExperimental — accuracy not yet measured
The passage indexed as Abstract says approximately 80% of isolates from neonatal E. coli meningitis possess the K1 capsule, supporting an estimated 20% without K1 in that population. It does not discuss the FilmArray ME panel or establish that its specific target is absent from those isolates; the estimate also does not apply to E. coli isolates generally. (LLM, conf=0.86)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our study had eight false negative results: 2 enterovirus; 1 Varicella-zoster virus; 2 cytomegalovirus (CMV); 2 HSV-1; and 1 E. coli.”
§ Outcomes of implementation of the FilmArray meningoencephalitis panel in a tertiary hospital between 2017 and 2020 > Results From October 2017 to October 2020, 1926 CSF samples were received in the Clinical Microbiology laboratory (Fig 1). Of those, 543 CSF samples from 512 individual patients were tested using the FilmArray ME panel. An abnormal WCC was noted for 329 samples (60.6%); no WCC was available for 26 blood-stained samples. A positive result was detected in 78 (14.4%) of all samples. Bacterial pathogens were detected in 22 samples and viral pathogens in 56 samples. In 466 samples, no target pathogen was detected. There was no positive result for Cryptococcus neoformans either via FilmArray ME panel, cryptococcal antigen testing or culture methods. Six CSF samples were positive for culture (2 beta-haemolytic group B streptococci, 3 Streptococcus pneumoniae and 1 Escherichia coli). Of 21 confirmed bacterial meningitis cases in our study, all patients had received at least one dose of antibiotic at the time of lumbar puncture. Positive results from the FilmArray ME panel are provided in Table 1. 103 CSF samples were referred to the NVRL, including confirmatory testing of viral targets in eight positive specimens, and a further 95 FilmArray-negative specimens were sent based on clinical suspicion of viral meningoencephalitis despite a negative FilmArray ME panel result, with particular emphasis on corroboratory testing with respect to suspicion of HSV-1 or 2 meningoencephalitis. Of importance, no bacterial pathogens were found on culture on the remaining 1383 samples that did not undergo molecular diagnostics. In the study, there were 2 confirmed false positive and 8 false negative results when the FilmArray ME panel were compared to reference laboratory results. Two false positive results were confirmed in our study, one for Streptococcus pneumonia and one HSV-2. Our study had eight false negative results: 2 enterovirus; 1 Varicella-zoster virus; 2 cytomegalovirus (CMV); 2 HSV-1; and 1 E. coli. Table 2 further describes these cases, including the clinical case and reference laboratory results. In our study, on further investigation of the false negative CMV results our reference laboratory limit of detection (LOD) was superior to the FilmArray ME panel, which explained the discordant result. The LOD of the FilmArray ME panel for CMV was 4300 copies/ml, far in excess of 57 copies/ml for the Artus CMV PCR assay (Qiagen, Hilden, Germany) performed in the NVRL [20].
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“One case with HHV-6 detected on the FilmArray ME panel was confirmed to be mumps meningitis which had mumps diagnostics not been performed, would have been erroneously deemed as a case as a HHV6 meningitis”
§ Outcomes of implementation of the FilmArray meningoencephalitis panel in a tertiary hospital between 2017 and 2020 > Discussion
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
35 more claims
Create a free account to see all 55 claims and every source verdict.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 8
Citations
Cites
Feigin, V. L., Nichols, E., Alam, T., Bannick, M. S., Beghi, E., Blake, N., Culpepper, W. J., Dorsey, E. R., Elbaz, A., Ellenbogen, R. G., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30499-x · Cited by 5,644
Clinical features and prognostic factors in adults with bacterial meningitis
van de Beek, D., de Gans, J., Spanjaard, L., Weisfelt, M., Reitsma, J. B., & Vermeulen, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040845 · Cited by 1,639
Acute Bacterial Meningitis in Adults -- A Review of 493 Episodes
Durand, M. L., Calderwood, S. B., Weber, D. J., Miller, S. I., Southwick, F. S., Caviness, V. S., & Swartz, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280104 · Cited by 1,344 · cited 1×
“However, it is noteworthy that pleocytosis was defined at a higher cut-off of�100 leukocytes/uL [3, 23].”
BackgroundTimbrook, T. T., Morton, J. B., McConeghy, K. W., Caffrey, A. R., Mylonakis, E., & LaPlante, K. L. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw649 · Cited by 569 · cited 1×
“meta-analyses of the benefits of rapid molecular diagnostic on mortality in blood stream infection [21].”
BackgroundChromosomally integrated human herpesvirus 6: questions and answers
Pellett, P. E., Ablashi, D. V., Ambros, P. F., Agut, H., Caserta, M. T., Descamps, V., Flamand, L., Gautheret‐Dejean, A., Hall, C. B., Kamble, R. T., et al. (2012) · Reviews in Medical Virology · doi:10.1002/rmv.715 · Cited by 377 · cited 1×
“Ten out of twelve positive results for HHV-6, of which 5 were confirmed by testing in the NVRL, were deemed not clinically significant based on clinical criteria and likely reflect chromosomal integration of the virus without evidence of meningoencephalitis [27].”
BackgroundTansarli, G. S., & Chapin, K. C. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.016 · Cited by 263 · cited 2×
“Our calculated specificity for viral targets was 99% and similar to studies included in the meta-analysis of Tansarli and Chapin [14].”
ResultMcGill, F., Griffiths, M. J., Bonnett, L. J., Geretti, A. M., Michael, B. D., Beeching, N. J., McKee, D., Scarlett, P., Hart, I. J., Mutton, K. J., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30245-7 · Cited by 193
Epidemiology of meningitis and encephalitis in the United States, 2011–2014
Hasbun, R., Rosenthal, N., Balada-Llasat, J. M., Chung, J., Duff, S., Bozzette, S., Zimmer, L., & Ginocchio, C. C. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix319 · Cited by 171
Aseptic meningitis in adults and children: diagnostic and management challenges
Shukla, B., Aguilera, E. A., Salazar, L., Wootton, S. H., Kaewpoowat, Q., & Hasbun, R. (2017) · Journal of Clinical Virology · doi:10.1016/j.jcv.2017.07.016 · Cited by 135 · cited 1×
“reported that 81% of patients with aseptic meningitis had indeterminate aetiologies despite further investigations [13].”
BackgroundNew Estimates of Incidence of Encephalitis in England
Granerød, J., Cousens, S., Davies, N. W. S., Crowcroft, N. S., & Thomas, S. L. (2013) · Emerging infectious diseases · doi:10.3201/eid1909.130064 · Cited by 129 · cited 1×
“Acute encephalitis has been estimated to cost the UK’s National Health Service over £23 million per year, but incidence is likely to be underestimated [10].”
Background
Cited by
Distinguishing community-acquired bacterial and viral meningitis: Microbes and biomarkers
Ivaska, L., Herberg, J., & Sadarangani, M. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.01.010 · Cited by 28
An Assessment of a New Rapid Multiplex PCR Assay for the Diagnosis of Meningoencephalitis
Cuesta, G., Puerta-Alcalde, P., Vergara, A., Roses, E., Bosch, J., Casals-Pascual, C., Soriano, A., Marcos, M. Á., Sanz, S., & Vila, J. (2024) · Diagnostics · doi:10.3390/diagnostics14080802 · Cited by 17
Healthcare-associated central nervous system infections
Ippolito, M., Giarratano, A., & Cortegiani, A. (2022) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000001167 · Cited by 15
Severe meningoencephalitis: epidemiology and outcomes
Thy, M., de Montmollin, É., Bouadma, L., Timsit, J., & Sonneville, R. (2023) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001087 · Cited by 7
García-Sánchez, C., Bloise, I., García‐Rodríguez, J., & Cendejas‐Bueno, E. (2023) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2023.116031 · Cited by 3
Metadata
- Authors
- Teoh, T., Powell, J., O’Keeffe, J., Donlon, E., Dillon, L., Lenihan, M., Mostyn, A., Power, L., Boers, P., Stapleton, P. J., O’Connell, N. H., & Dunne, C. P.
- Affiliations
- University of Limerick (IE)
- Corresponding author
- Dunne, Colum P.
- ORCID
- Venue
- PloS One
- Publisher
- Public Library of Science (PLoS)
- Published
- 2022-03-17
- Volume
- 17
- Issue
- 3
- Pages
- e0265187
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC8929653
- OpenAlex
- W4220713486
- Cited by
- 7
- References
- 25
- Citations by year
- 2024: 4 · 2023: 2 · 2022: 1
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Limerick Institutional Repository (University of Limerick) (acceptedVersion, cc-by-nc-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by-nc-sa)
- University of Limerick Institutional Repository (University of Limerick) (submittedVersion, cc-by-nc-sa)
- University of Limerick Institutional Repository (University of Limerick)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Keywords
- acute meningoencephalitis, cerebrospinal fluid diagnostics, multiplex PCR, bacterial meningitis, viral meningoencephalitis, aseptic meningitis, assay performance, clinical utility, mortality, length of hospital stay, hospital readmission, Gram staining
- MeSH terms
- Bacteria, Encephalitis, Humans, Meningitis, Meningitis, Aseptic, Meningitis, Viral, Meningoencephalitis, Multiplex Polymerase Chain Reaction, Tertiary Care Centers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Outcomes of implementation of the FilmArray meningoencephalitis panel in a tertiary hospital between 2017 and 2020. https://app.cochat.ai/papers/10.1371/journal.pone.0265187
- The paper
- Teoh, T., Powell, J., O’Keeffe, J., Donlon, E., Dillon, L., Lenihan, M., Mostyn, A., Power, L., Boers, P., Stapleton, P. J., O’Connell, N. H., & Dunne, C. P. (2022). Outcomes of implementation of the FilmArray meningoencephalitis panel in a tertiary hospital between 2017 and 2020. PloS One. https://doi.org/10.1371/journal.pone.0265187
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
